drugset
drugset / Trial / NCT06385145

A Bioavailability Study of Two Different PEG-rhGH Preparations.

NCT06385145 ↗

Phase 1 Completed 16 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations.

Timeline

Start
2024-05-08
Primary completion
2024-07-05
Completion
2025-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject PEG-rhGH Protein / enzyme biologic — Subcutaneous

Indications

pituitary deficiency